International Stem Cell CORP financial data

Symbol
ISCO on OTC
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 77% % 4.6%
Quick Ratio 29% % 4.8%
Debt-to-equity -128% % -1.6%
Return On Equity 2% % -91%
Return On Assets -1% % 91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8,004,389 shares 0%
Common Stock, Shares, Outstanding 8,004,389 shares 0%
Entity Public Float $222,031 USD -54%
Common Stock, Value, Issued $8,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 8,004,389 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 8,167,297 shares 2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $9,391,000 USD 10%
Cost of Revenue $3,957,000 USD 8.8%
Research and Development Expense $717,000 USD 17%
Selling and Marketing Expense $1,127,000 USD -9.7%
General and Administrative Expense $3,493,000 USD -2.2%
Costs and Expenses $9,294,000 USD 2.5%
Operating Income (Loss) $97,000 USD
Nonoperating Income (Expense) $156,000 USD -16%
Net Income (Loss) Attributable to Parent $59,000 USD 91%
Earnings Per Share, Basic 0 USD/shares 86%
Earnings Per Share, Diluted 0 USD/shares 86%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $1,015,000 USD 49%
Inventory, Net $1,591,000 USD 15%
Other Assets, Current $7,000 USD -30%
Assets, Current $3,734,000 USD 7%
Property, Plant and Equipment, Net $192,000 USD -34%
Operating Lease, Right-of-Use Asset $425,000 USD 4.4%
Intangible Assets, Net (Excluding Goodwill) $661,000 USD -11%
Assets $5,282,000 USD 2%
Accounts Payable, Current $265,000 USD -17%
Accrued Liabilities, Current $452,000 USD -4.8%
Liabilities, Current $4,655,000 USD -1.3%
Operating Lease, Liability, Noncurrent $103,000 USD -49%
Liabilities $4,758,000 USD -3.3%
Retained Earnings (Accumulated Deficit) $110,755,000 USD -0.05%
Stockholders' Equity Attributable to Parent $3,776,000 USD 6.6%
Liabilities and Equity $5,282,000 USD 2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $227,000 USD
Net Cash Provided by (Used in) Investing Activities $5,000 USD 44%
Common Stock, Shares Authorized 120,000,000 shares 0%
Common Stock, Shares, Issued 8,004,389 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $222,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $966,000 USD -26%
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,000 USD 0%
Deferred Tax Assets, Valuation Allowance $7,557,000 USD -3.8%
Deferred Tax Assets, Gross $7,666,000 USD -4.4%
Operating Lease, Liability $486,000 USD -6.2%
Payments to Acquire Property, Plant, and Equipment $5,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid $515,000 USD -9.2%
Property, Plant and Equipment, Gross $2,622,000 USD -0.23%
Operating Lease, Liability, Current $383,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid, Year Two $119,000 USD -67%
Lessee, Operating Lease, Liability, to be Paid, Year One $412,000 USD 14%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure -7.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29,000 USD -41%
Deferred Tax Assets, Operating Loss Carryforwards $5,208,000 USD -4.9%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $478,000 USD 0%
Additional Paid in Capital $106,966,000 USD 0.3%
Amortization of Intangible Assets $80,000 USD -3.6%
Depreciation, Depletion and Amortization $219,000 USD 5.7%
Deferred Tax Assets, Net of Valuation Allowance $109,000 USD -31%
Share-based Payment Arrangement, Expense $324,000 USD -35%
Interest Expense $37,000 USD 5.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%